全文获取类型
收费全文 | 51254篇 |
免费 | 4299篇 |
国内免费 | 443篇 |
专业分类
耳鼻咽喉 | 821篇 |
儿科学 | 1075篇 |
妇产科学 | 987篇 |
基础医学 | 8123篇 |
口腔科学 | 807篇 |
临床医学 | 4882篇 |
内科学 | 10354篇 |
皮肤病学 | 1691篇 |
神经病学 | 4436篇 |
特种医学 | 2940篇 |
外科学 | 5968篇 |
综合类 | 532篇 |
现状与发展 | 1篇 |
一般理论 | 16篇 |
预防医学 | 3310篇 |
眼科学 | 1350篇 |
药学 | 4330篇 |
1篇 | |
中国医学 | 433篇 |
肿瘤学 | 3939篇 |
出版年
2023年 | 299篇 |
2022年 | 811篇 |
2021年 | 1335篇 |
2020年 | 735篇 |
2019年 | 1139篇 |
2018年 | 1301篇 |
2017年 | 1024篇 |
2016年 | 1507篇 |
2015年 | 1948篇 |
2014年 | 2306篇 |
2013年 | 2721篇 |
2012年 | 3833篇 |
2011年 | 3723篇 |
2010年 | 2297篇 |
2009年 | 1940篇 |
2008年 | 2681篇 |
2007年 | 2685篇 |
2006年 | 2392篇 |
2005年 | 2271篇 |
2004年 | 1930篇 |
2003年 | 1716篇 |
2002年 | 1576篇 |
2001年 | 991篇 |
2000年 | 953篇 |
1999年 | 830篇 |
1998年 | 440篇 |
1997年 | 420篇 |
1996年 | 346篇 |
1995年 | 334篇 |
1994年 | 272篇 |
1993年 | 299篇 |
1992年 | 605篇 |
1991年 | 625篇 |
1990年 | 538篇 |
1989年 | 607篇 |
1988年 | 601篇 |
1987年 | 597篇 |
1986年 | 504篇 |
1985年 | 509篇 |
1984年 | 400篇 |
1983年 | 336篇 |
1982年 | 250篇 |
1981年 | 227篇 |
1980年 | 207篇 |
1979年 | 296篇 |
1978年 | 260篇 |
1977年 | 192篇 |
1974年 | 201篇 |
1973年 | 220篇 |
1972年 | 175篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
51.
52.
This study has shown that the retinae of Prototherian (egg-laying) mammals possess two neuronal types that are present in non-mammalian retinae, but absent or morphologically different in the retinae of Eutherian (placental) mammals. First, endogenous serotonin-like immunoreactivity has been localized in a population of presumptive amacrine cells in the platypus retina, the first such report in a mammalian retina. Second, the protein kinase C-immunoreactive (PKC-IR) bipolar cells in the echidna retina appear similar to the PKC-IR bipolars in the chicken retina, in that their dendrites give rise to a Landolt's club and their axons are multistratified. By contrast, the PKC-IR rod bipolar cells in the rabbit and in the brushtail possum, a Metatherian (marsupial) mammal, have no Landolt's clubs and their axons form terminal lobes in the innermost stratum of the inner plexiform layer. 相似文献
53.
54.
55.
Jin Woo Kim M.D. Ho Shik Kim M.D. In Kyung Kim M.D. Mee Ran Kim M.D. Eun Young Cho B.S. Heung Kee Kim M.D. Joon Mo Lee M.D. Sung Eun Namkoong M.D. 《Gynecologic oncology》1998,69(3):230-236
Transforming growth factor-β1 (TGF-β1) is known to be a potent growth inhibitor for many cell types, including most epithelial cells. In skin keratinocytes, TGF-β1 has been shown to inhibit growth and to rapidly reduce c-mycexpression. However, the molecular mechanism of TGF-β1 action on cell growth of cervical carcinoma has not yet been elucidated. We thus assessed the effect of TGF-β1 on the growth of cervical carcinoma cell lines. Two cervical squamous carcinoma cell lines, CUMC-3 and CUMC-6, were incubated with varying concentrations of TGF-β1, and growth inhibition was evaluated with tetrazolium-based colorimetric assay. After culture in TGF-β1 for 24 h, inhibition of growth was detected in a dose-dependent manner at concentrations of 0.1–10 ng/ml in both cell lines. This effect of TGF-β1 on cultured carcinoma cells was associated with apoptotic process including oligonucleosomal ladder DNA and apoptotic body formations. Northern blot analysis revealed c-mycmRNA expression was suppressed by 10 ng/ml of TGF-β1 following 3 h of treatment in both cell lines. Western blot analysis showed that the level of p27Kip1protein was increased after TGF-β1 treatment in both cell lines. These results suggest that the mechanisms by which TGF-β1 inhibits the growth of cervical carcinoma are complex and may include effects on down-regulation of c-mycgene, and overexpression of p27Kip1protein. 相似文献
56.
57.
58.
R C Young C P Downes D S Eggleston M Jones C H Macphee K K Rana J G Ward 《Journal of medicinal chemistry》1990,33(2):641-646
A new and convenient method for the preparation of the four stereoisomers of dihexadecanoyl phosphatidylinositol has been developed. An enantiomeric pair of acid-labile, pentaprotected myo-inositol building blocks was synthesized in high yield and coupled with chiral phenyl dihexadecanoylglyceryl phosphates to give the fully protected phosphatidylinositols. These were subsequently deprotected by hydrogenolysis and self-hydrolysis in aqueous ethanol to give the desired pure products. Comparison of these compounds as potential substrates for a partially purified phosphatidylinositol 4-kinase (EC 2.7.1.67) derived from human erythrocyte membranes revealed that the chirality of the inositol ring is crucial for efficient phosphorylation, whereas the chirality of the glycerol moiety is relatively unimportant. Moreover, the similarity in phosphorylation rates of the naturally occurring mammalian phospholipid, I, and its synthetic stereochemical counterpart, compound 10a, suggests that the enzyme is relatively tolerant to changes in fatty acid composition. 相似文献
59.
60.
CM Reid M. Nelson P. Beckinsale P. Ryan LMH Wing LJ Beilin MA Brown GLR Jennings CI Johnston J. Marley JJ McNeil TO Morgan J. Shaw ID Steven MJ West 《Clinical and experimental pharmacology & physiology》1997,24(5):370-373
1. The present study aimed to determine the feasibility of conducting a 5 year cardiovascular outcome trial of the treatment of 6000 elderly hypertensive patients in Australian general practices. 2. General practitioners (GPs) were invited to participate by mail and personal follow-up. Patient records were reviewed to identify subjects for a blood pressure (BP) screening programme. Blood pressure was measured on three occasions and eligible subjects were included if the average BP was 160 mmHg systolic or 90 mmHg diastolic if systolic BP was 140 mmHg. 3. Seven hundred and forty-one GPs were approached and 89 were enrolled in the study (12% of mail invites and 75% of those receiving a personal contact). In 16 practices where screening was completed, 82 000 records were reviewed to identify 4% patients eligible for screening. Twenty-two per cent of eligible subjects attended screening. Of 1938 subjects screened, 180 (9%) had BP 5=160/90 mmHg. Forty-seven percent of subjects (n = 916) were receiving antihypertensive therapy and 184 (20%) were withdrawn from therapy. One hundred and sixteen (63%) of these subjects had BP return to study entry levels within 6 weeks. Fifty-seven newly diagnosed and 81 previously treated subjects were randomized (7% of the screened population). 4. Based on the high participation rate of GPs, the response rate of patients to attend a BP screening programme and the 7% randomization to screening ratio for entry into the study, the ANBP2 pilot study has demonstrated that it is feasible to recruit subjects from Australian general practices to a cardiovascular outcome trial. 相似文献